These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21195175)

  • 1. Comparison of ibuprofen release from minitablets and capsules containing ibuprofen: β-cyclodextrin complex.
    Salústio PJ; Cabral-Marques HM; Costa PC; Pinto JF
    Eur J Pharm Biopharm; 2011 May; 78(1):58-66. PubMed ID: 21195175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules.
    El-Badry M; Alanazi FK; Mahrous GM; Alsarra IA
    Pharm Dev Technol; 2010; 15(5):500-10. PubMed ID: 19814584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies.
    di Cagno M; Stein PC; Skalko-Basnet N; Brandl M; Bauer-Brandl A
    J Pharm Biomed Anal; 2011 Jun; 55(3):446-51. PubMed ID: 21411261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin.
    Ghorab MK; Adeyeye MC
    Pharm Dev Technol; 2001 Aug; 6(3):305-14. PubMed ID: 11485172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a drug with wax-like properties as a melt binder.
    Dhumal RS; Shimpi SL; Chauhan B; Mahadik KR; Paradkar A
    Acta Pharm; 2006 Dec; 56(4):451-61. PubMed ID: 19839137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties.
    Jiang B; Hu L; Gao C; Shen J
    Int J Pharm; 2005 Nov; 304(1-2):220-30. PubMed ID: 16182477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and investigation of gemfibrozil + dimethyl-beta-cyclodextrin products and solid dosage forms].
    Hassan BH; Aigner Z; Kása P; Hódi K; Eros I
    Acta Pharm Hung; 2005; 75(3):125-32. PubMed ID: 16318236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M; Kosalec I; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
    Ribeiro L; Ferreira DC; Veiga FJ
    J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
    Weyenberg W; Vermeire A; D'Haese E; Vanhaelewyn G; Kestelyn P; Callens F; Nelis HJ; Remon JP; Ludwig A
    Eur J Pharm Sci; 2004 Sep; 23(1):77-87. PubMed ID: 15324925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.